The invention provides novel compounds having the general formula (I) wherein R1, X, Zlto Z5, L, n, the A ring, and the B ring, are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.Compounds (I) act as inhibitors of RIP1 kinase.
这项发明提供了具有一般式(I)的新化合物,其中R1、X、Z1至Z5、L、n、A环和B环如本文所述,包括这些化合物的药物组合物以及使用这些化合物的方法。化合物(I)作为RIP1激酶的
抑制剂。